stock price
Standard BioTools Lowers Full-Year Revenue Guidance as Q2 Revenues Fall 23 Percent
SomaScanassay services experienced service contract delays in Q2, impacting instrument sales, CEO Michael Egholm said.
360Dx Top 30 Jumps 11 Percent in July
Of the 30 companies in the index, 27 saw their share prices increase, while three saw their stock prices decline.
Illumina Completes Grail Divestment
Shares of Grail, issued by Illumina to its stockholders, opened at $18.89 but quickly fell 15 percent in Tuesday morning trading on the Nasdaq.
Craig-Hallum Upgrades CareDx to Buy
Analyst Bill Bonello said CareDx has substantially de-risked its business and could benefit from Medicare coverage of kidney transplant surveillance testing.
Quest Diagnostics Suggests Lab Staffing Crunch May Aid Hospital Strategy; Q1 Revenues up 2 Percent
Premium
The firm said its hospital reference testing business continued to grow at a faster rate than pre-pandemic, due in part to hospital staffing challenges.
Apr 1, 2024
360Dx Top 30 Rises 3 Percent in March
Mar 1, 2024
360Dx Top 30 Creeps up 1 Percent in February
Jan 3, 2024
360Dx Top 30 Falls 5 Percent in 2023
Dec 13, 2023
OpGen Requests Hearing on Nasdaq Delisting
Oct 13, 2023
T2 Biosystems Shares Plummet After Reverse Split
Oct 11, 2023
Oct 2, 2023
360Dx Top 30 Falls 10 Percent in September
Sep 26, 2023